UPDATED Apr 26, 2024
Over $1bn in market cap, profitable and undervalued based on cash flows.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$406.32 | 1.8% | 32.2% | US$3.0t | US$474.64 | PE35x | E12.3% | 0.7% | Software | ||
GOOGL | US$171.95 | 11.6% | 60.2% | US$2.1t | US$182.62 | PE25.8x | E11.7% | n/a | Media | ||
AMZN | US$179.62 | 2.9% | 70.3% | US$1.9t | US$210.77 | PE61.4x | E21.6% | n/a | Retail | ||
META | US$443.29 | -7.9% | 84.5% | US$1.1t | US$523.11 | PE24.6x | E12.2% | 0.5% | Media | ||
LLY | US$733.51 | 1.0% | 85.3% | US$660.7b | US$813.32 | PE126.1x | E27.2% | 0.7% | Pharmaceuticals & Biotech | ||
AVGO | US$1,344.07 | 11.6% | 114.5% | US$622.9b | US$1,500.96 | PE53.8x | E23.4% | 1.6% | Semiconductors | ||
2330 | NT$782.00 | 4.3% | 55.8% | NT$20.3t | NT$912.98 | PE23.7x | E16.1% | 1.8% | Semiconductors | ||
NOVO B | kr.886.60 | 2.4% | 57.7% | kr.4.0t | kr.904.20 | PE47.3x | E14.7% | 1.1% | Pharmaceuticals & Biotech | ||
JPM | US$193.49 | 4.1% | 40.0% | US$555.7b | US$206.36 | PB1.8x | E-1.5% | 2.4% | Banks | ||
WMT | US$60.16 | 1.1% | 19.5% | US$484.9b | US$65.08 | PE31.3x | E10.7% | 1.4% | Consumer Retailing | ||
XOM | US$117.96 | -1.6% | -0.3% | US$466.9b | US$129.81 | PE14.2x | E1.0% | 3.2% | Energy | ||
UNH | US$495.35 | -1.2% | 0.7% | US$455.8b | US$567.36 | PE29.7x | E19.2% | 1.5% | Healthcare | ||
700 | HK$348.40 | 14.7% | 1.2% | HK$3.2t | HK$418.15 | PE26.1x | E15.0% | 1.0% | Media | ||
PG | US$161.29 | 2.0% | 3.1% | US$380.7b | US$170.01 | PE25.6x | E7.2% | 2.3% | Household | ||
A005930 | ₩76,700.00 | -1.2% | 17.1% | ₩510.8t | ₩101,991.89 | PE36x | E27.4% | 1.9% | Tech | ||
JNJ | US$146.14 | -1.2% | -10.7% | US$352.2b | US$173.60 | PE18.4x | E5.1% | 3.4% | Pharmaceuticals & Biotech | ||
MRK | US$131.20 | 4.3% | 13.6% | US$332.3b | US$140.12 | PE144.1x | E25.9% | 2.3% | Pharmaceuticals & Biotech | ||
HD | US$335.09 | -0.08% | 11.5% | US$332.1b | US$384.83 | PE21.9x | E4.2% | 2.7% | Retail | ||
COST | US$729.18 | 2.8% | 44.9% | US$323.4b | US$776.41 | PE47.6x | E7.5% | 0.6% | Consumer Retailing | ||
ORCL | US$117.21 | 2.0% | 23.7% | US$322.2b | US$137.02 | PE30.3x | E14.7% | 1.4% | Software | ||
CVX | US$165.89 | 3.7% | -1.6% | US$306.5b | US$181.37 | PE15.1x | E3.1% | 3.9% | Energy | ||
BAC | US$37.83 | 2.3% | 29.2% | US$297.6b | US$39.70 | PB1.1x | E6.2% | 2.5% | Banks | ||
600519 | CN¥1,709.43 | 3.8% | -2.9% | CN¥2.1t | CN¥2,154.31 | PE28.7x | E12.8% | 2.9% | Food, Beverage & Tobacco | ||
ABBV | US$159.62 | -4.1% | 5.6% | US$282.6b | US$183.73 | PE47.5x | E24.2% | 3.9% | Pharmaceuticals & Biotech |